Valuation: Virbac

Market Cap 2.55B 2.9B 2.4B 2.19B 4.1B 278B 4.14B 28.86B 11.18B 142B 10.89B 10.65B 461B P/E 2026 *
14.6x
P/E 2027 * 13.1x
Enterprise Value 2.67B 3.04B 2.52B 2.3B 4.3B 292B 4.33B 30.24B 11.72B 148B 11.41B 11.16B 483B EV / Sales 2026 *
1.73x
EV / Sales 2027 * 1.58x
Free-Float
49.03%
Yield 2026 *
0.57%
Yield 2027 * 0.68%
1 day-0.82%
1 week-3.21%
Current month-6.36%
1 month-9.04%
3 months-9.99%
6 months-13.96%
Current year-15.52%
1 week 297
Extreme 297
314.5
1 month 297
Extreme 297
332
Current year 297
Extreme 297
389.5
1 year 297
Extreme 297
389.5
3 years 239
Extreme 239
400
5 years 215
Extreme 215
448.5
10 years 102.1
Extreme 102.1
448.5
Manager TitleAgeSince
Chief Executive Officer 46 31/08/2025
Chief Executive Officer 50 26/09/2024
Chief Operating Officer 64 31/12/2021
Director TitleAgeSince
Chairman 61 31/03/2006
Director/Board Member 68 27/07/2010
Director/Board Member 65 04/09/2017
Date Insider Type Main position Quantity % Market Cap. Importance
22/04/24 Sell

Chief Executive Officer

810 0.0096%
22/04/24 Sell

Chief Executive Officer

140 0.0017%
22/04/24 Sell

Chief Executive Officer

1,688 0.0200%
Change 5-day change 1-year change 3-year change Capi.($)
-0.82%-3.21%-3.67%+19.37% 2.91B
-1.87%-3.74%-50.73%-60.23% 29.59B
-0.97%-2.23%+20.55%+98.67% 11.28B
-3.46%-3.00%-13.95%-4.27% 3.84B
-2.98%-1.81%+27.52%+21.54% 1.91B
-0.98%+2.32%+19.91%+46.07% 1.91B
-0.50%-3.88%-11.69%+156.66% 1.38B
-2.80%-3.20%-20.02%-9.26% 1.16B
-0.60%-0.15%-5.68%-41.03% 1.02B
0.00%-0.26%-0.79%-5.27% 1B
Average -1.50%-1.15%-3.85%+22.22% 5.6B
Weighted average by Cap. -1.68%-1.64%-23.02%-6.10%

Financials

2026 *2027 *
Net sales 1.55B 1.76B 1.46B 1.33B 2.49B 169B 2.51B 17.5B 6.78B 85.94B 6.6B 6.46B 280B 1.64B 1.87B 1.55B 1.41B 2.64B 179B 2.67B 18.6B 7.21B 91.33B 7.02B 6.87B 297B
Net income 174M 198M 164M 150M 280M 18.98B 282M 1.97B 762M 9.66B 742M 726M 31.43B 194M 220M 183M 167M 312M 21.14B 314M 2.19B 849M 10.76B 827M 809M 35.02B
Net Debt 122M 139M 115M 105M 197M 13.36B 198M 1.38B 537M 6.8B 522M 511M 22.12B 44.72M 50.84M 42.16M 38.46M 71.93M 4.88B 72.49M 506M 196M 2.48B 191M 187M 8.08B
Logo Virbac
Virbac specializes in the research, production and marketing of veterinary medicines. Net sales break down by family of products as follows: - pet medications (60.7%): pest control drugs, vaccines, antibiotics, anesthetics, anti-inflammatory drugs, mouth/dental care products, ophthalmologic and dermatological products intended for dogs, cats, horses, birds, rodents, etc. The group also offers foods and electronic identification chips; - livestock medications (39.3%): pest control drugs and antibiotics intended for cattle, sheep, pigs, poultry, etc. Net sales are distributed geographically as follows: Europe (41.6%), Latin America (15.2%), North America (13.6%), India/Africa/Middle East (12.2%), Eastern Asia (10.5%) and Pacific (6.9%).
Employees
6,442
Date Price Change Volume
24/09/26 €302.00 -0.82% 4,422
23/09/26 €304.50 -0.98% 6,681
22/09/26 €307.50 0.00% 6,826
21/09/26 €307.50 -0.97% 4,906
18/09/26 €310.50 -1.27% 24,618
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
302.00EUR
Average target price
412.75EUR
Spread / Average Target
+36.67%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. VIRP Stock